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ABSTRACT: The β-galactosidase enzyme from Bacillus circulans ATCC 31382 BgaD is
widely used in the food industry to produce prebiotic galactooligosaccharides (GOS).
Recently, the crystal structure of a C-terminally truncated version of the enzyme (BgaD-D)
has been elucidated. The roles of active site amino acid residues in β-galactosidase enzyme
reaction and product speciﬁcity have remained unknown. On the basis of a structural
alignment of the β-galactosidase enzymes BgaD-D from B. circulans and BgaA from
Streptococcus pneumoniae, and the complex of BgaA with LacNAc, we identiﬁed eight active
site amino acid residues (Arg185, Asp481, Lys487, Tyr511, Trp570, Trp593, Glu601, and
Phe616) in BgaD-D. This study reports an investigation of the functional roles of these
residues, using site-directed mutagenesis, and a detailed biochemical characterization and
product proﬁle analysis of the mutants obtained. The data show that these residues are
involved in binding and positioning of the substrate and thus determine the BgaD-D
activity and product linkage speciﬁcity. This study provides detailed insights into the
structure−function relationships of the B. circulans BgaD-D enzyme, especially regarding
GOS product linkage speciﬁcity, allowing the rational mutation of β-galactosidase enzymes to produce speciﬁc mixtures of GOS
structures.
Prebiotics were ﬁrst deﬁned as “nondigestible foodingredients that beneﬁcially aﬀect the host by selectively
stimulating the growth and/or activity of one or a limited
number of bacterial species already resident in the colon, and
thus attempt to improve host health”.1 This concept has been
updated and adapted many times,2−4 but there is no doubt that
galactooligosaccharides (GOS) make up an important category
of prebiotics. GOS are a mixture of oligosaccharides produced
from lactose by β-galactosidase enzymes, comprising a number
of galactose units, with a terminal glucose or galactose.5−7 They
are produced via the double-displacement reaction catalyzed by
β-galactosidase enzymes. In the ﬁrst step, the glycosidic linkage
of lactose is cleaved, and the galactosyl unit covalently binds to
the enzyme forming a galactosyl−enzyme intermediate while
releasing the glucose. In the second step, an acceptor substrate
attacks the intermediate, resulting in formation of a product
with the galactosyl moiety. β-Galactosidase enzymes per-
form two reactions depending on the acceptor substrate.
With water serving as the acceptor substrate, galactose is
released via hydrolysis; with lactose or other carbohydrates
serving as acceptor substrates, GOS products are formed via
transgalactosylation.8−11
β-Galactosidase enzymes belong to glycoside hydrolase
(GH) families 1, 2, 35, and 42.12 The β-galactosidase from
Bacillus circulans ATCC 31382 (BgaD, GH2) is a 189 kDa
enzyme, and its commercial preparation, Biolacta N5, is widely
used in the food industry.13−15 BgaD has an activity toward
lactose higher than those of and a thermal stability better than
those of other β-galactosidase enzymes.16 A study investigated
the inﬂuence of organic solvents on the regioselectivity of BgaD
transglycosylation.17 The product speciﬁcity of BgaD with
lactose as a substrate was studied using methylation analysis,
mass spectrometry (MS), and nuclear magnetic resonance
spectroscopy; in this way, 11 GOS structures were identiﬁed.18
A detailed analysis of the commercial product Vivinal GOS,
synthesized by the B. circulans enzyme, resulted in identiﬁcation
of a total of 43 GOS structures.6,7 In B. circulans, BgaD is
present in diﬀerent isoforms resulting from C-terminal cleavage
by an endogenous protease.19 Three isoforms were reported by
Vetere and Paoletti;20 four isoforms (BgaD-A, BgaD-B, BgaD-C,
and BgaD-D) were reported in the commercial enzyme
preparation of β-galactosidase from B. circulans.19 In recent
years, these BgaD isoforms have been characterized in more
detail, facilitated by their cloning and recombinant over-
expression in Escherichia coli.21 All four isoforms have similar
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transgalactosylation activity at high lactose concentrations.9,22
The products synthesized by recombinant BgaD-D were also
studied in detail, showing a product proﬁle similar to that
of Vivinal GOS.6,7,10 Mutagenesis studies have shown that the
C-terminal discoidin domain of BgaD is essential for the hydro-
lytic activity of the enzyme.23 A few BgaD-D mutants have been
biochemically characterized in our previous work, resulting in
identiﬁcation of residues Glu532 and Glu447 as the nucleophile
and acid/base catalysts, respectively.9 Mutagenesis of the
Arg484 changed the GOS linkage speciﬁcity.11
The high-resolution crystal structure of the shortest isoform
of β-galactosidase from B. circulans [BgaD-D, Protein Data
Bank (PDB) code 4YPJ] was reported recently.24 Details of the
structure−function relationships of this enzyme determining its
GOS product linkage speciﬁcity have remained unknown. Here
we report the identiﬁcation and site-directed mutagenesis of
further residues in the active site of BgaD-D. Their functional
roles were characterized by analyzing the biochemical proper-
ties of the mutant enzymes and the structures of the GOS
produced. The data provide insight into how these residues
contribute to determining enzyme activity and GOS linkage
speciﬁcity.
■ EXPERIMENTAL PROCEDURES
Bacterial Strains. E. coli DH5α (Phabagen) was used for
DNA manipulation, and E. coli BL21 (DE3) was used for
protein expression.
Sequence and Structure Alignment. T-Coﬀee and
Jalview were used for the alignment of the amino acid
sequences of β-galactosidases from GH2 (Table 1 and Figure 1):
BgaD-D (E5RWQ2) from B. circulans ATCC 31382, BgaA
(A0A0H2UP19) from Streptococcus pneumoniae serotype 4,
BIF3 (Q9F4D5) from Bif idobacterium bif idum DSM 20215,
BbgIII (A4K5H9) from Bi. bif idum NCIMB 41171, and BbgIII
(D4QAP3) from Bi. bif idum. PyMOL (The PyMOL Molecular
Graphics System, version 1.2, Schrödinger, LLC) was used for
the structural alignment (Figure 2) of BgaD-D from B. circulans
(PDB code 4YPJ) and the nucleophile mutant (E645Q) of
BgaA in complex with N-acetyl-lactosamine (LacNAc) from S.
pneumoniae (PDB code 4CUC).
Site-Directed Mutagenesis. Plasmid pET-15b-LIC con-
taining the rBgaD-D-encoding gene from B. circulans was
obtained from a previous study and used as a template for
site-directed mutagenesis.10 On the basis of the results of the
sequence and structure alignments, mutations of residues
Arg185, Asp481, Lys487, Tyr511, Trp570, Trp593, Glu601,
and Phe616 were introduced by various primers (Table S1)
using the QuikChange site-directed mutagenesis kit (Strata-
gene). The polymerase chain reaction (PCR) products were
cleaned up with a PCR puriﬁcation kit after digestion by DpnI
(Thermo Fisher). Then the PCR products were transformed
into E. coli DH5α competent cells (Phabagen) via heat shock
for overnight growth on LB agar plates (containing 100 μg/mL
ampicillin). For every mutant, colonies were randomly chosen
and inoculated into 5 mL of LB medium (containing 100 μg/mL
ampicillin) for DNA ampliﬁcation overnight. The plasmid DNA
of the overnight cultures was puriﬁed using a miniprep kit
(Sigma-Aldrich) and sequenced (GATC Biotech).
Recombinant Protein Expression and Puriﬁcation.
The sequence-veriﬁed plasmids were transformed into E. coli
BL21 (DE3) (Invitrogen) competent cells for protein expres-
sion as described previously.10 Brieﬂy, after growth on LB agar
plates (containing 100 μg/mL ampicillin), colonies were
inoculated into 10 mL of LB medium (containing 100 μg/mL
ampicillin) for overnight preculture. The overnight cultures were
inoculated into 1 L of LB medium (containing 100 μg/mL
ampicillin) and incubated at 37 °C until the cell density reached
0.6 at 600 nm; then 1 mM isopropyl β-D-thiogalactopyranoside
was used for the induction of recombinant protein expression.
The cells were cultured at 30 °C overnight and harvested by
centrifugation at 10876g for 15 min. The cell pellets were
washed with 20 mM Tris-HCl buﬀer (pH 8.0) and centrifuged
again.
The cell pellets were lysed with B-PER protein extract
reagent (Thermo Scientiﬁc) at room temperature for 1 h. The
cell debris was removed by centrifugation; the remaining
supernatants were mixed with HIS-Select Nickel Aﬃnity Gel
(Sigma) and incubated at 4 °C overnight. Unbound proteins
were washed away with 20 mM Tris-HCl (pH 8.0) and 50 mM
NaCl. The recombinant proteins were eluted with 20 mM Tris-
HCl (pH 8.0) and 50 mM NaCl containing 100 mM imidazole.
Subsequently, the imidazole was removed by ultraﬁltration
(30 kDa cutoﬀ, Amicon, Merck)
Enzyme Activity Assay. For the activity assay of the wild-
type and mutant enzymes, 0.5−1 mg/mL (protein concen-
tration determined by a Nanodrop 2000 UV−vis spectropho-
tometer) amounts were incubated with 10% (w/w) lactose in
100 mM sodium phosphate buﬀer (pH 6.0) for 5 min at 40 °C.
The incubation mixtures were withdrawn and immediately
inactivated with 50 μL of 1.5 M NaOH. The reaction mixtures
were neutralized with 50 μL of 1.5 M HCl after 10 min. The
total activity (units) toward lactose was deﬁned as the amount
of enzyme required to release 1 μmol of Glc/min. The released
glucose was measured using a GOPOD kit (D-glucose Assay
Kit, Megazyme). The activity of the wild-type enzyme was
regarded as 100%; activities of all mutant enzymes were rela-
tive to that of the wild-type enzyme. The kinetic parameters
(Km and kcat) of mutant enzymes were determined using
10 diﬀerent lactose concentrations ranging from 10 to 500 mM.
GOS Production and Analysis. GOS were produced by
using 3.75 units/g lactose β-galactosidase wild-type and mutant
enzymes with 50% (w/w) lactose [in 100 mM sodium phos-
phate buﬀer (pH 6.0)] incubated at 60 °C for 20 h to reach the
highest GOS yield. We stopped the reactions by heating the
mixtures at 100 °C for 10 min.
The reaction mixtures were diluted 1000-fold with Milli-Q
water and analyzed by high-pH anion exchange chromato-
graphy (HPAEC) coupled with a pulsed amperometric detector
(PAD) on an ICS3000 chromatography workstation (Thermo-
Scientiﬁc). The analysis was performed by injecting 5 μL on a
Table 1. Comparison of the Amino Acid Sequences of
β-Galactosidase BgaD-D from B. circulans ATCC 31382 and













BIF3 Bi. bif idum DSM
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44 Q9F4D5
BbgIII Bi. bif idum NCIMB
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CarboPac PA1 analytical column (2 mm × 250 mm) with
the following elution buﬀers: (A) 100 mM sodium hydroxide,
(B) 600 mM sodium acetate in 100 mM sodium hydroxide,
(C) Milli-Q water, and (D) 50 mM sodium acetate. The
separation conditions were the same as used in our previous
study.10 The quantity of β-D-Galp-(1→3)-β-D-Galp-(1→4)-D-
Glcp was determined by using a calibration curve of this
compound (Sigma) ranging from 4 to 200 μg/mL. The com-
parisons of other GOS fractions were based on the peak
intensities of HPAEC−PAD proﬁles of the wild-type and mutant
enzymes. The quantiﬁcation of the GOS yield {GOS yield
(grams) = initial lactose (grams) − [remaining lactose (grams)
+ galactose (grams) + glucose (grams)] after 20 h} was based
on a calibration curve of galactose, glucose, and lactose ranging
from 10 to 1000 μM.
■ RESULTS
Structural Alignment. The β-galactosidase proteins BgaD-D
of B. circulans and BgaA of S. pneumonia share 49% sequence
identity. A structural alignment of BgaD-D (PDB code 4YPJ)
with the catalytic region of BgaA (PDB code 4CU6) and with
the inactive BgaA mutant E645Q in complex with LacNAc
(PDB code 4CUC) (Figure 2) guided our selection of active
site residues to be mutated. The residues targeted for mutagen-
esis were grouped in four sets, mainly based on their location in
the active site.
Site-Directed Mutagenesis and Enzyme Activity.
Mutations were introduced by site-directed random muta-
genesis as described in Experimental Procedures. The mutants
were obtained via two rounds of mutagenesis. Universal primer
pairs (Table S1) were used for the ﬁrst round, and 20 colonies
were selected randomly for sequencing. Speciﬁc primers
(Table S1) were used in the second round of mutagenesis
for a full coverage of amino acid (side chain) classes, or to
obtain a speciﬁc amino acid residue. The mutants obtained in
the two mutagenesis rounds and their relative enzyme activities
(release of Glc from lactose) are listed in Table 2. For residues
Arg185, Glu601, and Tyr511, a total of 6, 11, and 5 diﬀerent
mutants were obtained after two rounds, respectively; all
mutants were completely inactive (Table 2). Four Trp570
mutants were found in the ﬁrst round of mutagenesis; another
six mutants were selected in the second round. Of these
mutants, Trp570Tyr had the highest activity, 37.4 ± 0.4%
compared to that of the wild-type enzyme, followed by
Trp570Phe (16.1 ± 1.0%) and Trp570Leu (14.6 ± 0.8%). The
activity of the other Trp570 mutants was rather low (Table 2).
Figure 1. Sequence alignment of β-galactosidase enzymes in the GH2 family. Residues selected for mutagenesis and the catalytic residues in BgaD-D
from B. circulans ATCC 31382, Arg185, Glu447 (acid/base catalyst), Asp481, Lys487, Tyr511, Glu532 (nucleophile), Trp570, Trp593, Glu601, and
Phe616, are denoted with red arrows. The order of the sequences shown is the same as those listed in Table 1. The amino acid residue color coding
used is in Clustal X format. For details, see http://www.jalview.org/help/html/colourSchemes/clustal.html; gaps in the alignments are denoted with
hyphens.
Figure 2. Stereoview of the superposition of the active sites of the β-galactosidases BgaD-D (PDB code 4YPJ) of B. circulans ATCC 31382 and the
nucleophile mutant E645Q of BgaA from S. pneumoniae in complex with LacNAc (PDB code 4CUC). 4YPJ is colored slate blue and 4CUC brown,
and the catalytic residues of BgaD-D are colored cyan. Residues of BgaD-D are labeled in black and the corresponding residues in BgaA in gray.
Biochemistry Article
DOI: 10.1021/acs.biochem.7b00207
Biochemistry 2017, 56, 3109−3118
3111
One round of Trp593 mutagenesis yielded a total of 11 mutants.
Among them, only Trp593Tyr and Trp593Phe retained activity,
3.3 ± 0.2 and 70.7 ± 0.7% of the wild-type enzyme activity,
respectively (Table 2). For Phe616, a total of eight mutants
were obtained in the ﬁrst round. With the speciﬁc primers, the
other 11 mutants were also obtained. Phe616Trp (37.2 ±
1.5%) and Phe616Tyr (73.2 ± 0.6%) had the highest activity
among all these mutants (Table 2). In the ﬁrst round, six
mutants of Asp481 were acquired, and another seven mutants
were obtained in the second round. Only Asp481Glu, Asp481His,
Asp481Ser, Asp481Asn, and Asp481Gln retained very little
activity (Table 2). For Lys487, the universal primers resulted
in eight mutants; most of them had relatively high activity (65.5
± 0.8 to 105.5 ± 1.2%), except for Lys487Cys (3.5 ± 0.4%)
(Table 2).
Catalytic Properties. On the basis of the activity com-
pared to that of the wild-type (WT) enzyme, and interesting
product proﬁles (see the next section), the catalytic properties
of a selection of enzymes were determined (Table 3). For all
enzymes, the kcat was lower (12.3 ± 1.1 to 184.7 ± 3.4 s
−1) than
that of the WT enzyme (199.8 ± 5.3 s−1), while the substrate
aﬃnity (Km) ranged from 21.9 ± 4.7 to 246.5 ± 66.0 mM; the
WT enzyme has a Km of 112.9 ± 12.7 mM.
11 The catalytic eﬃ-
ciency (kcat/Km) of the WT enzyme is 1780.7 ± 152.0 s
−1 M−1;
Table 2. Relative Total Activities (release of Glc from lactose) of the Various B. circulans ATCC 31382 β-Galactosidase BgaD-D
Mutant Proteins
site round mutant relative activitya site round mutant relative activity
WT 100 Phe616 1 Val 1.9 ± 0.01
Arg185 1 Glu b Glu 1.4 ± 0.01
Gly b Gly 3 ± 0.1
Leu b Lys 0.8 ± 0.01
Pro b Gln 3.2 ± 0.08
Ser b Arg 1.3 ± 0.01
Lys b Asp 4.6 ± 0.1
Glu601 1 Pro b Leu 22.9 ± 1.6
Phe b 2 Trp 37.2 ± 1.5
Gln b His 13.4 ± 0.2
His b Ser 5.3 ± 1.1
Ala b Thr 4.9 ± 0.03
Arg b Asn 11.6 ± 0.1
Tyr b Cys 3.9 ± 0.08
Cys b Pro 3.8 ± 0.7
Gly b Ala 3.4 ± 0.1
Thr b Ile 2.8 ± 0.04
2 Asp b Met 1.4 ± 0.05
Tyr511 1 Cys b Tyr 73.2 ± 0.6
Pro b Asp481 1 Tyr b
Ser b Phe b
2 Trp b Glu 7.3 ± 0.5
Phe b His 2.1 ± 0.6
Trp570 1 Gly 5.1 ± 0.08 Ala b
Thr 6.5 ± 0.2 Ser 6.1 ± 0.2
Arg 3.6 ± 0.1 2 Lys b
Glu 5.2 ± 0.3 Arg b
2 Tyr 37.4 ± 0.4 Asn 6.7 ± 0.3
Phe 16.1 ± 1.0 Gln 3.3 ± 0.3
Ala 4.2 ± 0.05 Leu b
Val 3.0 ± 0.1 Trp b
Cys 6.1 ± 0.1 Gly b
Leu 14.6 ± 0.8 Lys487 1 Met 105.5 ± 1.2
Trp593 1 Val b Phe 73.2 ± 0.7
Leu b Leu 93.7 ± 0.4
Ser b Gln 83.1 ± 0.6
Ala b Ser 76.3 ± 0.9
Gly b Gly 65.5 ± 0.9
Thr b Asn 65.5 ± 0.8
Pro b Cys 3.5 ± 0.4
Gln b
Tyr 3.3 ± 0.2
Phe 70.7 ± 0.7
His b
aTotal activity. Activities of all mutant enzymes are relative to that of the wild-type (WT) enzyme (100%, 103.4 μmol min−1 mg−1). Enzyme activity
was measured in triplicate experiments with 10% (w/w) lactose at 40 °C. bActivity not detectable (detection limit of 0.1 mg/mL glucose).
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in almost all mutants, the eﬃciency was lower (178.4 ± 16.5 to
1546.3 ± 50.0 s−1 M−1), except for Trp593Phe that has a much
higher kcat/Km of 2990.2 ± 184.2 s
−1 M−1.
Mutant GOS Proﬁles. For the wild type (WT) and a
selection of mutant enzymes showing suﬃcient activity, incuba-
tions using 3.75 units/g of lactose were performed for 20 h,
and the HPAEC−PAD GOS product proﬁles were compared
(Figure 3).
Because galactose is released by hydrolysis, the hydrolysis
activity is reﬂected by the intensity of peak 1 (galactose). For all
three Trp570 mutants, the hydrolysis activity increased, as
evidenced by the increased intensity of peak 1 in the HPAEC−
PAD proﬁle (Figure 3A), whereas the hydrolytic activity of all
Trp593 and Phe616 mutant enzymes was comparable with that
of the WT enzyme [peak 1 (Figure 3B,C)]. Most notable
changes in relative product intensities were observed in struc-
tures 8, 11, 13, and 17 for the mutant enzymes at Trp570,
Trp593, and Phe616 (Table 4). In the case of Trp570Tyr and
Trp570Phe, structures 8a [β-D-Galp-(1→2)-D-Glcp] and 8b
[β-D-Galp-(1→3)-D-Glcp] were similar in level to that of the
WT enzyme, whereas the levels of the (β1→4) elongations
(peaks 13a and 13b) signiﬁcantly increased. Levels of structures
11 [β-D-Galp-(1→4)-β-D-Galp-(1→4)-D-Glcp] and its (β1→4)
elongation (peak 17) were signiﬁcantly decreased. In the case
of Trp593Tyr and Trp593Phe, a similar observation was made,
except that levels of structures 8a and 8b also were increased
compared to the WT product proﬁle. Mutant Trp570Leu
showed a completely diﬀerent proﬁle, with a hydrolytic activity
much higher than those of any of the other mutants. The
HPAEC−PAD proﬁle showed two major product peaks for 11
and 17 and only minor peaks for other products. However,
quantitation of the peaks (Table 4) showed that peak 11 is
comparable with that of the WT enzyme, while all other peaks
showed a reduced product yield.
Enzymes with a mutation at Phe616 showed HPAEC−PAD
proﬁles very similar to that of the WT enzyme. Quantitation of
peaks 8, 11, 13, and 17 showed some diﬀerences in intensity
compared with the WT enzyme, but the changes were mostly
minor. In case of Phe616 Trp, -Asn, and -Tyr mutants, levels of
structures 11 and 17 were slightly increased, while levels of 8
and 13 were either slightly decreased or the same compared to
that of the WT. For the other Phe616 mutants, the intensities
showed the opposite response (Table 4).
Mutations at Asp481 and Lys487 showed diﬀerent eﬀects on
the product proﬁles (Figure 3D,E). Mutation of Asp481 to Glu,
Ser, or Asn reduced the intensity of peaks 8, 11, and 13
(Table 5), whereas the intensity of peak 12 [β-D-Galp-(1→3)-
β-D-Galp-(1→4)-D-Glcp] increased signiﬁcantly. Whereas
the WT enzyme produces only minor amounts of 12 (0.2 ±
0.05 g/100 g of lactose), all three mutants produced a sig-
niﬁcant amount of 12. Notably, in case of Asp481Asn, the
intensity of peak 4 [β-D-Galp-(1→4)-D-Glcp] also was
increased (Figure 3D).
Changing Lys487 to a Met, Leu, or Gln had no signiﬁcant
eﬀect on the product proﬁle, also evidenced by quantitation of
peaks 8 and 11−13 (Table 5). Mutation of this residue to Phe
or Asn resulted in a reduced yield for 8 and 13, while the yields
of 11 and 12 both increased. The most remarkable changes
were observed for mutants Ly487Ser and Lys487Gly, showing a
signiﬁcant increase in 12, even up to 9.7 ± 1.1 g/100 g of
lactose.
■ DISCUSSION
Prebiotic GOS produced from lactose by β-galactosidase
enzymes are drawing a great deal of attention; they have
been added to infant formula because their molecular size is
similar to that of human milk oligosaccharides and because of
their beneﬁcial functions and positive eﬀects on intestinal
health.25−28 The beneﬁcial functions of GOS were further
shown by studies regarding calcium absorption, metabolic
activities, and protection against colorectal cancer.29−32 To
understand how diﬀerent β-galactosidases synthesize such a
range of GOS structures, and how they may be tailored to
produce more speciﬁc GOS mixtures, it is essential to obtain
detailed (three-dimensional) structural information about both
the enzymes and their GOS products. Although several crystal
structures of β-galactosidase enzymes have been determined
and served to improve our understanding of the enzyme
reaction mechanism,33−36 their detailed structure−function
relationships are still largely unexplored, especially regarding
their GOS product linkage speciﬁcity.
In this study, we have characterized the functional roles of
eight amino acid residues in the active site of BgaD-D from B.
circulans ATCC 31382, close to the substrate binding site,
constituting four groups.
Arg185 and Glu601 Are Essential for Activity and
Substrate Binding. Arg185 and Glu601 are located near the
nonreducing end hydroxyl groups of the lactosyl moiety of
LacNAc in subsite −1 (Figure 4A). All six mutants of Arg185,
and all 11 mutants of Glu601, had lost detectable enzyme
activity. As shown in Figure 4A, Arg185 and Glu601 in 4YPJ
correspond to Arg288 and Glu716 in S. pneumoniae BgaA,
respectively; they are located at the −1 subsite of BgaA and are
hydrogen-bonded to the 4-OH group of the galactosyl unit of
LacNAc (Figure 4A). Given the conservation of these residues,
it is likely that Arg185 and Glu601 in BgaD-D have a similar
essential function, namely assisting in the binding and posi-
tioning of the substrate.
Tyr511 Is Essential for Activity. Residue Tyr511 is
conserved among the GH2 family β-galactosidase enzymes
(Figure 1); both in BgaA and in BgaD, its OH group makes a
hydrogen bond interaction (2.6 Å) to the nucleophilic Glu
residue. The nearby nucleophilic residue Glu532 attacks the
substrate while it is productively bound; a previous study
proposed that Tyr511 assists in the catalytic mechanism by
donating its proton to Glu532, before it attacks the substrate to
form the covalent galactosyl−enzyme intermediate.24 None of
the mutants obtained were active. Our experimental results
Table 3. Kinetic Properties of the B. circulans ATCC 31382
Wild-Type β-Galactosidase BgaD-D and Mutant Proteins
enzyme Km
a (mM) kcat
a (s−1) kcat/Km (s
−1 M−1)
WTb 112.9 ± 12.7 199.8 ± 5.3 1780.7 ± 152.0
Trp570Tyr 75.6 ± 11.0 27.2 ± 0.9 398.6 ± 20.0
Trp570Phe 246.5 ± 66.0 44.6 ± 7.1 178.4 ± 16.5
Trp593Phe 21.9 ± 4.7 63.6 ± 0.6 2990.2 ± 184.2
Phe616Trp 180.0 ± 8.0 114.7 ± 3.5 587.7 ± 5.2
Phe616His 156.1 ± 9.8 48.9 ± 1.8 321.3 ± 27.2
Phe616Tyr 112.6 ± 3.9 183.9 ± 4.0 1504.6 ± 57.2
Asp481Gln 57.4 ± 13.8 12.3 ± 1.1 217.9 ± 37.9
Lys487Ser 119.5 ± 5.6 184.7 ± 3.4 1546.3 ± 50.0
Lys487Gly 176.8 ± 12.6 177.7 ± 7.1 1001.5 ± 37.2
aKinetic parameters (Km and kcat) were determined with 10 diﬀerent
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conﬁrm that the hydroxyl group of Tyr511 is essential for
enzymatic activity.
Residues Trp570, Trp593, and Phe616 Form an
Aromatic Pocket Shaping the Substrate Binding Site.
Trp570 is located near the +1 subsite, while Trp593 and
Phe616 are located near the −1 subsite (Figure 4B). From the
10 mutants of Trp570, Trp570Tyr retained 37.4 ± 0.4% of
the WT activity (Table 2). The kcat of Trp570Tyr decreased
7.3-fold compared to that of the wild-type enzyme, while the
Km decreased 1.5-fold (Table 3). Trp570Phe retained 16.1 ±
1.0% of the WT activity; for the other substitutions, the activity
was lower (Table 2). The kcat of Trp570Phe decreased 4.5-fold,
while the Km increased 2.2-fold (Table 3). The kinetic param-
eters of Trp570Tyr and Trp570Phe show that the mutations at
this site have a stronger inﬂuence on the turnover rate (kcat)
than on Km and may aﬀect acceptor binding. The GOS yields of
the Trp570Tyr and Trp570Phe mutants were comparable with
that of the WT enzyme (63.5 ± 0.8 g of GOS from 100 g of
initial lactose), while Trp570Leu can produce only 43.8 ± 0.7 g
of GOS from 100 g of initial lactose (Table 4). Mutants
Trp570Tyr and Trp570Phe produced more of structure 8
and less of structures 11 and 17, showing their preference
for (β1→2) and (β1→3) over (β1→4) linkages. In contrast,
Trp570Leu produced only 21.8 ± 0.5% of structure 8
compared to the wild type (100%), and the yield of structures
further elongated from this (structure 13) was too low to be
quantiﬁed. The Trp570Leu yield of structure 11 was com-
parable to that of the wild-type enzyme. These results show
the strong preference of this mutant to synthesize GOS with
(β1→4) linkages. Notably, these three mutants also have a
Figure 3. HPAEC−PAD analysis of the GOS proﬁles produced by B. circulans ATCC 31382 BgaD-D WT and mutant enzymes: (A) Trp570
mutants, (B) Trp593 mutants, (C) Phe616 mutants, (D) Asp481 mutants, (E) Lys487 mutants, and (F) the annotated major GOS structures. WT
and mutant enzymes (3.75 units/g of lactose) were incubated with 50% (w/w) lactose (structure 5) for 20 h at 60 °C.
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higher hydrolytic activity, as evidenced by a much higher yield
of galactose (structure 1) compared to that of the wild-type
enzyme (Figure 3A), i.e., 3.0, 5.9, and 10.1 times that of the
wild type for Trp570Tyr, Trp570Phe, and Trp570Leu, respec-
tively. Among the mutants of Trp593, activity was observed for
only Trp593Tyr and Trp593Phe (3.3 ± 0.2 and 70.7 ± 0.7%,
respectively) (Table 2). Both the Km and the kcat of Trp593Phe
decreased (Table 3), resulting in a relatively low activity (70.7
± 0.7%) compared to that of the wild-type enzyme (Table 2).
As shown in panels B and F of Figure 3 and Table 4, the GOS
yields of mutants Trp593Tyr and Trp593Phe were comparable
to that of the wild-type enzyme. These two mutants synthesized
more of structures 8 and 13 and less of structures 11 and 17,
showing their preference for (β1→2) and (β1→3) over
(β1→4) linkages.
In the case of Phe616, the Phe616Tyr mutant had the
highest activity, with 73.2 ± 0.6% of WT activity remaining,
followed by Phe616Trp, which has 37.2 ± 1.5% of the WT
activity (Table 2). The kinetic parameters (Km and kcat) of
Phe616Tyr changed slightly compared to those of the wild-type
enzyme (Table 3). For Phe616Trp, the Km increased while the
kcat decreased (Table 3), resulting in a much lower activity.
Phe616Trp produced more of structures 11 and 17 and less
of structures 8 and 13 (Table 4), showing its preference for
synthesizing (β1→4) linkages. In contrast, Phe616Leu has a
preference for synthesizing (β1→2) and (β1→3) linkages
(Figure 3C and Table 4).
The aromatic pocket formed by residues Trp570, Trp593,
and Phe616 in BgaD shapes its active site. We found that
mutations at these positions negatively aﬀected enzyme activity,
especially when the mutations were non-aromatic. Moreover,
they changed the linkage preference and size of the products.
For example, Trp570Leu produced only 21.8 ± 0.5% of
structure 8 compared to the wild-type enzyme, and its elonga-
tion product, structure 13, was not detectable. Apparently, the
mutation enhanced the percentage of small oligosaccharides
produced, achieving similar results as reported in a previous
study.37 Our results also show that Trp570 is essential for the
transgalactosylation and hydrolysis activities, suggesting that it
is involved in selection of the acceptor substrate, either water or
carbohydrates. Together, the observed eﬀects of mutations of
residues in the aromatic pocket suggest that the geometry of
this pocket is important to recognize and orient donor and
acceptor substrates.
Table 4. Total GOS Yields and Yields of the Major GOS Structures 8, 11, 13, and 17 Obtained for the B. circulans ATCC 31382
BgaD-D Trp570, Trp593, and Phe616 Mutants, Compared to the Wild-Type Enzymea
enzyme GOS yieldb structure 8 yieldc structure 11 yieldc structure 13 yieldc structure 17 yieldc
WTd 63.5 ± 0.8 100 100 100 100
Trp570Tyr 65.8 ± 1.7 133.5 ± 0.9 52.7 ± 1.0 103.8 ± 1.6 41.3 ± 1.0
Trp570Phe 65.4 ± 0.9 110.1 ± 0.7 44.1 ± 0.5 91.6 ± 2.0 31.0 ± 0.6
Trp570Leu 43.8 ± 0.7 21.8 ± 0.5 93.9 ± 3.1 e 67.9 ± 2.7
Trp593Phe 66.0 ± 1.0 122.5 ± 5.1 65.7 ± 1.7 126.2 ± 5.1 53.7 ± 1.6
Trp593Tyr 65.2 ± 2.1 146.6 ± 7.2 49.3 ± 2.1 128.4 ± 1.9 35.4 ± 1.9
Phe616Trp 50.8 ± 2.4 80.8 ± 1.7 132.1 ± 7.2 75.7 ± 0.8 119.8 ± 6.0
Phe616Leu 61.0 ± 1.4 114.4 ± 1.6 91.3 ± 3.1 120.2 ± 2.5 82.7 ± 3.3
Phe616His 59.6 ± 1.2 99.8 ± 3.3 93.4 ± 1.5 110.6 ± 0.8 80.4 ± 2.4
Phe616Asn 57.3 ± 1.4 82.0 ± 2.6 106.5 ± 8.0 93.6 ± 4.7 97.3 ± 9.6
Phe616Tyr 58.3 ± 0.6 105.9 ± 4.3 108.0 ± 0.1 114.9 ± 2.0 108.3 ± 0.5
aGOS was produced using 3.75 units/mL β-galactosidase wild-type and mutant enzymes with 50% (w/w) lactose [in 100 mM sodium phosphate
buﬀer (pH 6.0)] incubated at 60 °C for 20 h. bYields are calculated as grams of GOS produced from 100 g of initial lactose. Calibration curves for
lactose, galactose, and glucose ranging from 10 to 1000 μM were used for quantiﬁcation. cThe yields are relative to that of the wild-type enzyme
(100%), estimated by comparing the peak intensities in the HPAEC−PAD proﬁles. dData from our previous study.11 eUnable to quantify.
Table 5. Total GOS Yields and Yields of the Major GOS Structures 8 and 11−13 Obtained for the B. circulans ATCC 31382
BgaD-D Asp481 and Lys487 Mutants, Compared to the Wild-Type Enzymea
enzyme GOS yieldb structure 8 yieldc structure 11 yieldc structure 12 yieldd structure 13 yieldc
WTe 63.5 ± 0.8 100 100 0.2 ± 0.05 100
Asp481Glu 56.4 ± 2.2 51.5 ± 2.0 47.5 ± 1.5 4.8 ± 0.8 17.1 ± 3.2
Asp481Ser 55.3 ± 3.6 59.3 ± 1.9 70.1 ± 4.1 2.6 ± 0.4 30.3 ± 3.1
Asp481Asn 68.8 ± 1.7 68.5 ± 2.9 16.6 ± 0.8 4.9 ± 0.8 20.2 ± 4.7
Lys487Met 59.0 ± 1.9 99.8 ± 1.5 97.3 ± 3.2 f 103.2 ± 3.4
Lys487Phe 58.3 ± 1.5 74.7 ± 0.2 105.6 ± 1.3 1.6 ± 0.2 68.7 ± 1.0
Lys487Leu 59.1 ± 1.1 101.3 ± 0.7 101.9 ± 2.4 f 97.7 ± 4.1
Lys487Gln 58.6 ± 2.9 98.9 ± 1.2 98.8 ± 1.7 f 98.1 ± 2.9
Lys487Ser 63.6 ± 1.0 77.5 ± 3.1 68.2 ± 1.3 5.0 ± 0.4 57.5 ± 3.7
Lys487Gly 62.0 ± 2.7 63.1 ± 0.2 66.0 ± 2.7 9.7 ± 1.1 36.9 ± 3.7
Lys487Asn 59.8 ± 1.3 68.5 ± 1.8 104.4 ± 5.0 1.7 ± 0.2 58.5 ± 2.0
aGOS was produced using 3.75 units/mL β-galactosidase wild-type and mutant enzymes with 50% (w/w) lactose [in 100 mM sodium phosphate
buﬀer (pH 6.0)] incubated at 60 °C for 20 h. bYields are calculated as grams of GOS produced from 100 g of initial lactose. Calibration curves for
lactose, galactose, and glucose ranging from 10 to 1000 μM were used for quantiﬁcation. cThe yields are relative to that of the wild-type enzyme
(100%), estimated by comparing the peak intensities in the HPAEC−PAD proﬁles. dYields are expressed as grams of product obtained from 100 g of
initial lactose. A calibration curve of structure 12 [β-D-Galp-(1→3)-β-D-Galp-(1→4)-D-Glcp] ranging from 4 to 200 μg/mL was used for its
quantiﬁcation. eData from our previous study.11 fNot detectable.
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Asp481 and Lys487 Are Involved in Determining
Linkage Speciﬁcity. Asp481, Arg484, and Lys487 are located
near subsite +1 (Figure 4C). Mutations of the ﬁrst residue
(Asp481) dramatically reduced the enzyme activity. Among all
mutants, only ﬁve (Glu, His, Ser, Asn, and Gln) retained some
activity (Table 2). Because Asp481 is relatively close to the
acid/base catalyst Glu447 (3.9 Å), mutations at this position
may aﬀect the orientation and/or acidity of Glu447 and thus
inﬂuence catalysis. Mutation Asp481Gln increased the substrate
binding aﬃnity (Km decreased 2-fold) but decreased the turn-
over rate (kcat decreased 16-fold) (Table 3). The GOS proﬁles
of the Asp481 mutants changed strongly compared to that of
the wild-type enzyme (Figure 3D). The amounts of all major
GOS structures produced by the wild-type enzyme (structures
8, 11, and 13) decreased, while that of structure 12 increased
signiﬁcantly (Table 5), similar to results found previously for
mutations of Arg484.11 It is also notable that with mutant
Asp481Asn, the yield of allolactose (structure 4) increased
2.3-fold compared to that of the wild-type enzyme (Figure 3D).
The results show that the mutations at this site favor synthesis
of GOS with (β1→3) and (β1→6) linkages. In BgaA of S.
pneumoniae, the corresponding Asp599 (Asp481 in BgaD)
forms a hydrogen bond with the 6-OH group of the GlcNAc
moiety at the +1 subsite (Figure 4C); thus, considering its
position and interaction, Asp481 may play a role in acceptor
substrate binding.
The third residue in this group, Lys487, is relatively far
from the +1 subsite (Figure 4C). The activity of its mutants is
relatively high compared to those of the other mutant enzymes
except for Lys487Cys, retaining only 3.5 ± 0.4% of WT activity
(Table 2). Compared to those of the wild-type enzyme, the Km
and kcat values of Lys487Ser showed only minor changes. In
comparison, the Km value of Lys487Gly increased by 57% and
resulted in a lower catalytic eﬃciency (kcat/Km = 1010). Com-
pared with those of the wild-type enzyme, the GOS proﬁles and
the relative amounts of the major structures did not change
signiﬁcantly for Lys487Met, Lys487Leu, or Lys487Gln.
Mutants Lys487Phe, Lys487Ser, Lys487Gly, and Lys487Asn
all have increased yields of structure 12 (Figure 3E and
Table 5). Especially for Lys487Gly, the yield of structure 12 is
comparable to that of Arg484Ser and Arg484His.11 The latter
mutations thus favor the synthesis of GOS with (β1→3)
linkages. Considering the slightly larger distance from the +1
site, mutations of Lys487 may change the microenvironment
of the +1 subsite, therefore aﬀecting the linkage speciﬁcity
indirectly.
■ CONCLUSIONS
In conclusion, we pinpointed several residues in the active site
of BgaD that are important for the β-galactosidase reaction
activity and speciﬁcity, by aﬀecting substrate binding or
transglycosylation speciﬁcity. Residues Arg185 and Glu601 at
subsite −1 are essential for the β-galactosidase reaction because
they aﬀect substrate binding. A tyrosine residue near the cat-
alytic residues (Tyr511) is also essential for the enzyme activity.
An aromatic triplet (Trp570, Trp593, and Phe616) shaping the
Figure 4. Superposition of the B. circulans ATCC 31382 BgaD-D residues (PDB code 4YPJ) subjected to mutagenesis [(A) Arg185, Glu601, and
Tyr511, (B) Trp570, Trp593, and Phe616, and (C) Asp481 and Lys487] with the nucleophile mutant (E645Q) of BgaA of S. pneumoniae in complex
with LacNAc (PDB code 4CUC). The color coding and labeling are the same as in Figure 2.
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active site is important for correct substrate binding and
determining the linkage distribution. Residues in or near subsite
+1 (Asp481, Asp484, and Lys487) may aﬀect the acceptor
substrate orientation. Mutants derived produced large amounts
of the trisaccharide β-D-Galp-(1→3)-β-D-Galp-(1→4)-D-Glcp
(structure 12) in the product mixture, thus leading to more
diverse GOS mixtures with potential industrial applications.
Our study thus provides important insights into the under-
standing of the structure−function relationships of β-galac-
tosidase enzymes, especially regarding their GOS product
linkage speciﬁcity, and provides guidance for rational protein
engineering of these enzymes with the aim of producing tailor-
made prebiotic GOS mixtures.
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